ライフサイエンスコーパス: nonmucinous

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ic survival than mucinous adenocarcinoma and nonmucinous adenocarcinoma patients (log-rank, P < 0.001

2 approximately 5 mm; (c) lepidic predominant nonmucinous adenocarcinoma, representing histopathologic

3 mongst the 42 nodules of the 9 patients with nonmucinous adenocarcinoma, the mean tumor-to-background

4 HPV DNA was not detected in any nonmucinous adenocarcinomas including clear cell, serous

5 Nonmucinous but not mucinous tumors were significantly a

6 ding 54% (7/13) of mucinous and 63% (5/8) of nonmucinous carcinomas.

7 carcinomas, consisting of 17 mucinous and 11 nonmucinous carcinomas.

8 urate test for differentiating mucinous from nonmucinous cystic lesions.

9 urve (0.79) for differentiating mucinous vs. nonmucinous cystic lesions.

10 accuracy to distinguish between mucinous and nonmucinous cysts.

11 ability to distinguish between mucinous and nonmucinous cysts.

12 p15.1 is strongly associated with high grade nonmucinous epithelial ovarian cancer.

13 nocarcinoma that shows predominantly lepidic nonmucinous growth, which at CT is usually part solid bu

14 0.82-2.52) and 1.90 (95% CI: 0.95-3.80) for nonmucinous histology, respectively.

15 hich 1375 had mucinous histology and 860 had nonmucinous histology.

16 h pathologically proved mucinous (n = 9) and nonmucinous (n = 17) rectal tumors, MR imaging was perfo

17 % are mucinous and have worse prognoses than nonmucinous ones.

18 minimally deleted regions were identified in nonmucinous ovarian cancer.

19 Women with nonmucinous ovarian carcinoma (n = 1,001) enrolled onto

20 hould be offered to all women diagnosed with nonmucinous, ovarian carcinoma, regardless of family his

21 ant adenocarcinoma are now described, all as nonmucinous, predominantly invasive, may include a small

22 Mucinous and nonmucinous rectal tumors can be differentiated with MR

23 ugh overall CSS was similar for mucinous and nonmucinous subtypes, differences in stage distribution

24 tly higher in the mucinous compared with the nonmucinous tumors (P = .0004, P = .0008, and P = .00002

25 e odds ratio was 0.89 (95% CI 0.85-0.93) for nonmucinous tumors and 0.98 (95% CI 0.93-1.04) for mucin

26 (95% confidence interval (CI) 0.69-0.85) for nonmucinous tumors and 1.03 (95% CI 0.88-1.21) for mucin

27 ) was significantly and inversely related to nonmucinous tumors but not to mucinous tumors.

28 fference in odds ratios between mucinous and nonmucinous tumors).

29 The risk of nonmucinous tumors, but not mucinous tumors, was positiv

30 Among women with nonmucinous tumors, increasing trends in risk of invasiv

31 Overexpression of PAFR was found in most nonmucinous types of ovarian cancer but not in HOSE and

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。